
WASHINGTON, Oct. 9 (UPI) -- An company in Iceland, DeCode Genetics, has developed a genetic test to screen for risk of the most common forms of breast cancer.
The company said the DNA-based test, performed using a blood sample or cheek swab, measures seven widely replicated single-letter variations (SNPs) in the human genome that DeCode and others have linked to risk of breast cancer.
"Women will then receive a numerical score representing their relative risk of developing breast cancer in their lifetime compared to that of the general population, as well as their personal lifetime risk," the company said Wednesday in a news release.
The Washington Post reported critics have expressed concern the $1,625 test could falsely reassure some women and needlessly alarm others. "Women should know this test is not recommended by any organization," Debbie Saslow of the American Cancer Society told the newspaper.
|
|
|
|
|
|
| Additional Science News Stories | |
WASHINGTON, May 31 (UPI) --
The U.S. House Thursday rejected a bill that would outlaw abortions based on gender, with abortion opponents promising to make the vote an election issue.
|
NEW YORK, May 31 (UPI) --
Actor Michael McKean, who was hit by a car last week while walking in New York, says he has been discharged from St. Luke's Hospital.
|
BALTIMORE, May 31 (UPI) --
U.S. astronomers are forecasting the Milky Way will have a violent collision with the neighboring Andromeda galaxy in about 4 billion years.
|
CLEVELAND, May 31 (UPI) --
Cleveland prosecutors have dropped their case against a man who was ticketed for littering when he dropped a dollar he was attempting to give a disabled person.
|
| Stories | Photos | People | Comments |
View Caption